EC8 Stock Overview A medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
CONMED Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for CONMED Historical stock prices Current Share Price US$60.00 52 Week High US$77.50 52 Week Low US$56.00 Beta 1.47 1 Month Change -8.40% 3 Month Change -11.76% 1 Year Change -20.00% 3 Year Change -50.82% 5 Year Change -32.20% Change since IPO 294.61%
Recent News & Updates
CONMED Corporation Provides Financial Guidance for the First Quarter and Full Year of 2025 Feb 06
CONMED Corporation to Report Q4, 2024 Results on Feb 05, 2025 Jan 07
CONMED Corporation Declares Quarterly Cash Dividend, Payable on January 3, 2025 Dec 10
Investor sentiment improves as stock rises 17% Nov 07
New minor risk - Earnings quality Nov 04
CONMED Corporation Revises Earnings Guidance for the Full Year 2024 Nov 02 See more updates
CONMED Corporation Provides Financial Guidance for the First Quarter and Full Year of 2025 Feb 06
CONMED Corporation to Report Q4, 2024 Results on Feb 05, 2025 Jan 07
CONMED Corporation Declares Quarterly Cash Dividend, Payable on January 3, 2025 Dec 10
Investor sentiment improves as stock rises 17% Nov 07
New minor risk - Earnings quality Nov 04
CONMED Corporation Revises Earnings Guidance for the Full Year 2024 Nov 02
Third quarter 2024 earnings released: EPS: US$1.59 (vs US$0.52 in 3Q 2023) Nov 01
CONMED Corporation Announces Chief Executive Officer Changes Nov 01 CONMED Corporation Announces Chief Executive Officer Changes
CONMED Corporation to Report Q3, 2024 Results on Oct 30, 2024 Oct 04
Upcoming dividend of US$0.20 per share Sep 09
Second quarter dividend of US$0.20 announced Aug 19
CONMED Corporation Announces Termination of Stanley W. (Bill) Peters as President, Advanced Surgical & Advanced Endoscopic Technologies, Effective August 31, 2024 Aug 15
Second quarter 2024 earnings released: EPS: US$0.97 (vs US$0.45 in 2Q 2023) Aug 01
CONMED Corporation Revises Earnings Guidance for the Full Year 2024 Aug 01
CONMED Corporation to Report Q2, 2024 Results on Jul 31, 2024 Jul 09
Upcoming dividend of US$0.20 per share Jun 10
First quarter dividend of US$0.20 announced May 26
CONMED Corporation Declares Quarterly Cash Dividend, Payable on July 5, 2024 May 23
First quarter 2024 earnings released: EPS: US$0.64 (vs US$0.06 in 1Q 2023) Apr 25 CONMED Corporation Revises Earnings Guidance for the Full Year 2024
CONMED Corporation, Annual General Meeting, May 22, 2024 Apr 09
CONMED Corporation to Report Q1, 2024 Results on Apr 24, 2024 Apr 03
Upcoming dividend of US$0.20 per share Mar 07
Fourth quarter dividend of US$0.20 announced Mar 04
Full year 2023 earnings released: EPS: US$2.10 (vs US$2.68 loss in FY 2022) Mar 01
CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024 Feb 28
Full year 2023 earnings released: EPS: US$2.10 (vs US$2.68 loss in FY 2022) Feb 01
CONMED Corporation Provides Financial Guidance for the Full Year 2024 Feb 01
Investor sentiment deteriorates as stock falls 16% Jan 26
CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2024 Dec 06
Third quarter 2023 earnings released: EPS: US$0.52 (vs US$1.51 in 3Q 2022) Oct 26
CONMED Corporation Updates Third Quarter Guidance for 2023 Oct 26
CONMED Corporation to Report Q3, 2023 Results on Oct 25, 2023 Oct 05
Upcoming dividend of US$0.20 per share at 0.7% yield Sep 07
CONMED Corporation Announces Quarterly Cash Dividend, Payable on October 5, 2023 Aug 11
Second quarter 2023 earnings released: EPS: US$0.45 (vs US$5.65 loss in 2Q 2022) Jul 27
CONMED Corporation Revises Earnings Guidance for the Full Year 2023 Jul 27
CONMED Corporation to Report Q2, 2023 Results on Jul 26, 2023 Jul 06
Upcoming dividend of US$0.20 per share at 0.6% yield Jun 07
CONMED Corporation Announces Quarterly Cash Dividend, Payable on July 5, 2023 May 25
Insider recently sold €151k worth of stock May 03
First quarter 2023 earnings released: EPS: US$0.06 (vs US$0.51 in 1Q 2022) Apr 28
Chairman of the Board recently sold €433k worth of stock Mar 16
Upcoming dividend of US$0.20 per share at 0.8% yield Mar 07
Full year 2022 earnings released: US$2.68 loss per share (vs US$2.15 profit in FY 2021) Feb 05
CONMED Corporation Provides Earnings Guidance for the Full Year 2023 Feb 03
CONMED Corporation to Report Q4, 2022 Results on Feb 02, 2023 Jan 10
Now 21% undervalued after recent price drop Dec 08
CONMED Corporation Announces Management Changes Dec 08
CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2023 Dec 06
Insufficient new directors Nov 16
CONMED Corporation Provides Revenue Guidance for the Full Year 2023 Nov 16
Insufficient new directors Nov 01
Third quarter 2022 earnings released: EPS: US$1.51 (vs US$0.51 in 3Q 2021) Oct 27
CONMED Corporation Revises Earnings Guidance for the Full Year 2022 Oct 27
CONMED Corporation to Report Q3, 2022 Results on Oct 26, 2022 Oct 11
Insufficient new directors Oct 02
Chairman of the Board recently sold €329k worth of stock Sep 18
Upcoming dividend of US$0.20 per share Sep 07
CONMED Corporation Announces Quarterly Cash Dividend, Payable on October 5, 2022 Aug 12
CONMED Corporation (NYSE:CNMD) completed the acquisition of Biorez, Inc. Aug 11
CONMED Corporation (NYSE:CNMD) completed the acquisition of Biorez, Inc. Aug 10
CONMED Corporation (NYSE:CNMD) has entered into a definitive agreement to acquire Biorez, Inc. for $250 million. Aug 03
CONMED Corporation (NYSE:CNMD) has entered into a definitive agreement to acquire Biorez, Inc. for $250 million. Aug 02
Second quarter 2022 earnings released: US$5.65 loss per share (vs US$0.46 profit in 2Q 2021) Jul 28
CONMED Corporation Revises Earnings Guidance for the Full Year 2022 Jul 28
CONMED Corporation to Report Q2, 2022 Results on Jul 27, 2022 Jul 06
CONMED Corporation(NYSE:CNMD) dropped from Russell 2000 Dynamic Index Jun 26
CONMED Corporation (NYSE:CNMD) completed the acquisition of In2Bones Global, Inc. Jun 14
Upcoming dividend of US$0.20 per share Jun 07
CONMED Corporation Announces Quarterly Cash Dividend, Payable on July 5, 2022 May 26
CONMED Corporation Announces Quarterly Cash Dividend, Payable on July 5, 2022 May 25
Independent Director recently sold €826k worth of stock May 18
Now 21% undervalued after recent price drop May 07
First quarter 2022 earnings released: EPS: US$0.51 (vs US$0.34 in 1Q 2021) May 06
CONMED Corporation (NYSE:CNMD) agreed to acquire In2Bones Global, Inc. for approximately $260 million. May 06 CONMED Corporation Revised Earnings Guidance for the Fiscal 2022
CONMED Corporation to Report Q1, 2022 Results on Apr 27, 2022 Apr 01
Chairman of the Board recently sold €316k worth of stock Mar 24 CONMED Corporation Announces Executive Changes Mar 10
Upcoming dividend of US$0.20 per share Mar 07
CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2022 Mar 01
Independent Director recently sold €776k worth of stock Feb 06
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Jan 28
CONMED Corporation Provides Earnings Guidance for the Full Year 2022 Jan 27
Upcoming dividend of US$0.20 per share Dec 08
Insider recently sold €2.2m worth of stock Nov 06
Third quarter 2021 earnings released: EPS US$0.51 (vs US$0.24 in 3Q 2020) Oct 28
Executive VP of Legal Affairs recently sold €361k worth of stock Sep 18
Upcoming dividend of US$0.20 per share Sep 07
Second quarter 2021 earnings released: EPS US$0.46 (vs US$0.96 loss in 2Q 2020) Jul 30
Executive VP & CFO recently sold €108k worth of stock Jun 18
Upcoming dividend of US$0.20 per share Jun 07
Chairman of the Board recently sold €4.6m worth of stock Jun 05
CONMED Corporation Declares Quarterly Cash Dividend, Payable July 6, 2021 May 21 Shareholder Returns EC8 DE Medical Equipment DE Market 7D 0.8% -4.3% -1.3% 1Y -20.0% -5.1% 14.9%
See full shareholder returns
Return vs Market: EC8 underperformed the German Market which returned 19.3% over the past year.
Price Volatility Is EC8's price volatile compared to industry and market? EC8 volatility EC8 Average Weekly Movement 5.0% Medical Equipment Industry Average Movement 6.9% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.6% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: EC8 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: EC8's weekly volatility (5%) has been stable over the past year.
About the Company CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.
Show more CONMED Corporation Fundamentals Summary How do CONMED's earnings and revenue compare to its market cap? EC8 fundamental statistics Market cap €1.85b Earnings (TTM ) €126.09m Revenue (TTM ) €1.24b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) EC8 income statement (TTM ) Revenue US$1.31b Cost of Revenue US$573.98m Gross Profit US$733.03m Other Expenses US$600.61m Earnings US$132.42m
Last Reported Earnings
Dec 31, 2024
Earnings per share (EPS) 4.28 Gross Margin 56.08% Net Profit Margin 10.13% Debt/Equity Ratio 93.9%
How did EC8 perform over the long term?
See historical performance and comparison Dividends
1.3% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/20 18:11 End of Day Share Price 2025/02/20 00:00 Earnings 2024/12/31 Annual Earnings 2024/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources CONMED Corporation is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Travis Steed Barclays Travis Steed BofA Global Research Kristen Stewart CL King & Associates, Inc.
Show 11 more analysts 
